查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828148

2025年鼻腔给药技术全球市场报告

Nasal Drug Delivery Technology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，鼻腔给药技术市场规模强劲成长，从2024年的807.9亿美元增加至2025年的852.3亿美元，复合年增长率为5.5%。这段历史时期的成长可归因于药物製剂的进步、呼吸系统疾病盛行率的上升、患者对非侵入性给药方式的偏好、老年人口的不断增长以及监管机构对鼻腔给药核准的支持。

预计未来几年，鼻腔给药技术市场将强劲成长，到2029年将达到1,182.2亿美元，年复合成长率（CAGR）为8.5%。预测期内的增长可归因于生技药品和胜肽类疗法的兴起、对儿科和老年患者需求的关注、製药行业内的联盟与合作、非处方 (OTC) 鼻腔产品的扩张以及对精准医疗的日益关注。预测期内的主要趋势包括製剂技术的进步、对患者友善设备的日益关注、治疗领域的拓展、生技药品和胜肽给药以及滴鼻剂技术的创新。

鼻腔给药技术旨在透过鼻腔给药，将药物在血液中的浓度迅速提高到治疗水平，有可能实现透过嗅觉神经元将药物直接输送到大脑，绕过血脑障壁（BBB）并最大限度地减少肝臟和肠道的处理。

此技术的主要剂型包括滴鼻剂、滴鼻剂、鼻凝胶、软膏和粉末。滴鼻剂喷出大量细小液滴，冲洗鼻腔并将药物输送至全身。它们有加压和非加压两种包装，用途广泛，包括治疗过敏性和非过敏性鼻炎、鼻塞、气喘和疫苗接种。这些产品可透过各种分销管道购买，包括医院药房、零售店和线上药房，并供最终用户使用，包括居家医疗机构和医院。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司最新报告系列的一部分，该系列提供了您在鼻腔给药技术行业取得成功所需的所有数据，涵盖鼻腔给药技术市场统计数据，例如全球市场规模、区域份额、鼻腔给药技术市场份额的竞争对手、详细的鼻腔给药技术细分市场、市场趋势和商业机会。本鼻腔给药技术市场研究报告提供了完整的行业观点，并深入分析了该行业的现状和未来前景。

未来五年8.5%的预测成长率，较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。这直接影响了美国，包括对德国精密喷雾喷嘴的贸易限制，从而提高了滴鼻剂的生产成本，并可能推迟治疗方法偏头痛和荷尔蒙疗法的新方法。由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响，其影响也将更加广泛。

慢性病盛行率的上升预计将推动鼻腔给药技术市场的成长。慢性病是指持续时间超过一年、需要持续医疗照护并可能限制日常活动的健康状况。鼻腔给药技术用于治疗慢性鼻窦炎，透过针对鼻腔复杂结构量身定制的治疗方法，增强细菌生物膜管理和黏膜清除。例如，根据总部位于美国的非营利医疗组织美国心臟病学会 2022 年 8 月发布的报告，预计从 2025 年到 2060 年，所有四大心血管危险因子都将增加。尤其是糖尿病，预计增加 39.3%，达到 5,500 万例。其次是血脂异常症（增加 27.6%，达到 1.26 亿例）、高血压（增加 25.1%，达到 1.62 亿例）和肥胖（增加 18.3%，达到 1.26 亿例）。此外，心血管疾病预计也将大幅成长，包括中风（成长33.8%，达到1,500万）、心臟衰竭（成长33.4%，达到1,300万）、缺血性心臟疾病（成长30.7%，达到2,900万）以及心臟病发作（成长16.9%，达到1,600万）。因此，慢性病盛行率的上升正在推动鼻腔给药系统市场的扩张。

预计全球老年人口（通常为 65 岁及以上）的不断增长将推动鼻腔给药技术市场的成长。这种给药方式由于其易于使用且患者依从性更高，有助于克服该年龄层面临的吞嚥药丸困难，在老年人中越来越受欢迎。例如，2024 年 1 月，专注于收集和提供统计数据的美国非营利组织人口研究所预测，65 岁及以上美国的数量将增加 47%，从 2022 年的 5800 万增加到 2050 年的 8,200 万。此外，65 岁及以上人口的比例预计将从 17% 上升到 23%。因此，全球老年人口的成长将有助于鼻腔给药技术市场的扩张。

产品创新是塑造鼻腔给药技术格局的关键趋势。领先的製药公司正在积极开发新型给药方法，以巩固其市场地位。例如，2023年1月，阿普塔集团（AptarGroup, Inc.）推出了APF Futurity，这是首款可回收、无金属、多鼻喷雾，专为生理食盐水和同等非处方药（OTC）製剂设计。这款创新产品的可回收设计已获得AA级认证，有助于提高回收效率。

此次技术进步的合作彰显了公司在鼻腔给药领域的策略重点。具体而言，2023年11月，Hobbione与工业设计顾问公司（IDC）合作开发了先进的鼻腔粉末给药装置。这些装置提供精准的给药方案—局部、全身给药或鼻-脑给药—并展现出多功能性和可靠性。此次合作旨在加速两款创新型鼻腔粉剂给药装置的上市，以满足多样化的给药需求，并简化药物开发和生产流程。

2022年5月，美国医疗设备製造商Medtronic Inc.）收购了Intersect ENT Inc.，收购金额未揭露。此次收购为Medtronic的整体耳鼻喉 (ENT) 产品组合增添了用于改善鼻窦手术后疗效和治疗鼻息肉的新产品。 Intersect ENT Inc. 是一家总部位于美国的耳鼻喉医疗设备製造商。

鼻腔给药技术市场的主要企业包括 AptarGroup Inc.、Becton Dickinson and Company、GlaxoSmithKline plc、Johnson & Johnson Private Limited、Novartis AG、Pfizer Inc.、3M Company、Cadila Healthcare Limited、Neurelis Inc.、OptiNose Inc.、Bausch Health Companies Inc.、Nave Ltd. Pharmaceuticals Ltd.、ENT Technologies Pty. Ltd.、Merck & Co. Inc.、Sanofi SA、AstraZeneca plc、Boehringer Ingelheim International GmbH、Bayer AG、Abbott Laboratories、Eli Lilly and Company、Bristol-Myers Squibb 工业, Pharmaceutical plc、Regeneron Pharmaceuticals Inc. 与 Alexion Pharmaceuticals Inc.

2024 年，北美是鼻腔给药技术市场最大的地区。鼻腔给药技术市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

鼻腔给药技术市场报告涵盖以下国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙

鼻腔给药技术市场由提供鼻腔给药服务、脑部标靶治疗和黏膜疫苗接种等服务的营业单位所获得的收益所构成。市场价值包括服务提供者销售的或包含在其服务产品中的相关产品的价值。鼻腔给药技术市场还包括用于提供鼻腔给药技术服务的导管输送药物、雾化器和压力定量吸入器 (PMDI) 设备的销售。该市场的价值为“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球鼻腔给药技术：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球鼻腔给药技术市场：成长率分析
  • 全球鼻腔给药技术市场表现：规模与成长，2019-2024
  • 全球鼻腔给药技术市场预测：规模与成长，2024-2029年，2034年
  • 全球鼻腔给药技术：总目标市场（TAM）

第六章 市场细分

  • 全球鼻腔给药技术市场（依剂型划分）：2019-2024 年、2024-2029 年、2034 年表现及预测
  • 鼻喷剂
  • 滴鼻剂
  • 鼻用凝胶和软膏
  • 鼻粉
  • 其他剂型
  • 全球鼻腔给药技术市场（按容器类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 压力容器
  • 非加压容器
  • 全球鼻腔给药技术市场（依治疗应用、效能与预测），2019-2024 年、2024-2029 年、2034 年
  • 过敏性和非过敏性鼻炎
  • 鼻塞
  • 气喘
  • 疫苗接种
  • 其他治疗用途
  • 全球经鼻给药技术市场（依分销管道）：2019-2024 年、2024-2029 年、2034 年业绩及预测
  • 医院药房
  • 零售药局
  • 网路药局
  • 全球鼻腔给药技术市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 居家照护环境
  • 医院
  • 全球鼻腔给药技术市场：依鼻喷剂类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 定量喷雾
  • 非定量喷雾
  • 全球鼻腔给药技术市场：滴鼻剂类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 液态滴鼻剂
  • 凝胶型滴鼻剂
  • 全球鼻腔给药技术市场：依鼻腔凝胶及软膏（按类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 水凝胶配方
  • 油性软膏
  • 全球鼻腔给药技术市场：依鼻腔粉末类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 干粉吸入器（DPI）
  • 喷雾干燥粉末
  • 全球鼻腔给药技术市场：依其他剂型（按类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 鼻贴
  • 鼻插入物

第七章 区域和国家分析

  • 全球鼻腔给药技术市场：依地区、绩效及预测，2019-2024年、2024-2029年、2034年
  • 全球鼻腔给药技术市场：国家、绩效与预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 鼻腔给药技术市场：竞争格局
  • 鼻腔给药技术市场：公司简介
    • AptarGroup Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Pfizer Inc.
  • 3M Company
  • Cadila Healthcare Limited
  • Neurelis Inc.
  • OptiNose Inc.
  • Bausch Health Companies Inc.
  • Naveh Pharma Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Consort Medical plc
  • Douglas Pharmaceuticals Ltd.
  • ENT Technologies Pty. Ltd.
  • Merck & Co. Inc.
  • Sanofi SA
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年鼻腔给药技术市场：提供新机会的国家
  • 2029年鼻腔给药技术市场：细分领域带来新机会
  • 2029年鼻腔给药技术市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24358u

Nasal drug delivery technology involves administering pharmaceuticals through the nasal cavity, aiming to rapidly achieve therapeutic drug levels in the bloodstream and potentially enable direct drug delivery to the brain via olfactory neurons. This method bypasses the blood-brain barrier (BBB) and undergoes minimal processing in the liver and intestines.

Key dosage forms for this technology include nasal spray, nasal drops, nasal gels, ointments, powders, and others. Nasal spray devices expel numerous tiny liquid drops to cleanse the nose or deliver medication to the body. They are available in pressurized and non-pressurized containers and are applied across diverse uses such as allergic and non-allergic rhinitis, nasal congestion, asthma, vaccination, and more. These products are accessible through various distribution channels such as hospital pharmacies, retail outlets, and online pharmacies, and are utilized by end-users including home care settings and hospitals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The nasal drug delivery technology market research report is one of a series of new reports from The Business Research Company that provides nasal drug delivery technology market statistics, including nasal drug delivery technology industry global market size, regional shares, competitors with a nasal drug delivery technology market share, detailed nasal drug delivery technology market segments, market trends, and opportunities, and any further data you may need to thrive in the nasal drug delivery technology industry. This nasal drug delivery technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nasal drug delivery technology market size has grown strongly in recent years. It will grow from $80.79 billion in 2024 to $85.23 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to advancements in drug formulations, increasing prevalence of respiratory disorders, patient preference for non-invasive delivery, expanding geriatric population, regulatory support for nasal drug approvals.

The nasal drug delivery technology market size is expected to see strong growth in the next few years. It will grow to $118.22 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rise in biologics and peptide therapies, focus on pediatric and geriatric patient needs, partnerships and collaborations in the pharma industry, expansion of over-the-counter (OTC) nasal products, increased focus on precision medicine. Major trends in the forecast period include advancements in formulation technology, increased focus on patient-friendly devices, expansion of therapeutic areas, biologics and peptides delivery, innovations in nasal spray technologies.

The forecast of 8.5% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through trade restrictions on precision spray nozzles from Germany, raising production costs for nasal mist medications and delaying new treatments for migraines and hormone therapies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases is projected to stimulate growth in the nasal drug delivery technology market. Chronic diseases are defined as health conditions that persist for a year or more and necessitate continuous medical care, potentially limiting daily activities. Nasal drug delivery technologies are utilized to manage chronic rhinosinusitis, enhancing bacterial biofilm management and mucociliary clearance through a therapeutic approach tailored for the intricate structure of the nasal cavity. For example, a report by the American College of Cardiology, a nonprofit medical association based in the United States, published in August 2022, indicates that all four primary cardiovascular risk factors are expected to rise from 2025 to 2060. Among these, diabetes is anticipated to experience the most significant increase, rising by 39.3% to reach 55 million individuals. This is followed by dyslipidemia (up 27.6% to 126 million), hypertension (up 25.1% to 162 million), and obesity (up 18.3% to 126 million). Furthermore, substantial rises in cardiovascular disease rates are expected, including stroke (33.8% increase to 15 million) and heart failure (33.4% increase to 13 million), with ischemic heart disease (up 30.7% to 29 million) and heart attack (up 16.9% to 16 million) not far behind. As a result, the increasing prevalence of chronic diseases is fueling the expansion of the nasal drug delivery systems market.

The growth of the nasal drug delivery technology market is anticipated to be driven by the increasing global geriatric population. The geriatric population consists of individuals who are generally 65 years old and above. This drug delivery method is favored among older adults due to its ease of use and improved patient adherence, helping to overcome difficulties associated with pill swallowing in this age group. For example, in January 2024, the Population Reference Bureau, a nonprofit organization in the US that focuses on collecting and providing statistics, projected that the number of Americans aged 65 and older will grow from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, the proportion of the population aged 65 and older is expected to rise from 17% to 23%. Consequently, the increase in the geriatric population worldwide will contribute to the expansion of the nasal drug delivery technology market.

Product innovation stands as a pivotal trend shaping the landscape of nasal drug delivery technology. Leading pharmaceutical companies are actively engaged in developing novel drug administration methods to bolster their market positions. For instance, in January 2023, AptarGroup, Inc. introduced APF Futurity, the first recyclable, metal-free, multidose nasal spray designed for nasal saline and equivalent OTC formulations. This innovative product's recyclability design has garnered Class AA certification, promoting greater recycling efficiency.

Collaborative efforts aimed at technological advancements highlight the strategic focus within the nasal drug delivery sector. Notably, in November 2023, Hovione collaborated with Industrial Design Consultancy (IDC) to develop advanced nasal powder delivery devices. These devices offer precise drug delivery options for local, systemic, or nose-to-brain applications, showcasing versatility and reliability. The collaboration's objective is to expedite the release of two innovative nasal powder delivery devices, catering to diverse drug delivery needs while streamlining drug product development and manufacturing processes.

In May 2022, Medtronic plc, a US-based medical device firm, acquired Intersect ENT Inc. for an undisclosed sum. The acquisition will add novel products used in sinus operations to enhance post-operative outcomes and treat nasal polyps to Medtronic's entire ear, nose, and throat (ENT) portfolio. Intersect ENT Inc. is a US-based medical device firm operating in ear, nose, and throat medical technology.

Major companies operating in the nasal drug delivery technology market include AptarGroup Inc., Becton Dickinson and Company, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Novartis AG, Pfizer Inc., 3M Company, Cadila Healthcare Limited, Neurelis Inc., OptiNose Inc., Bausch Health Companies Inc., Naveh Pharma Ltd., Teva Pharmaceutical Industries Ltd., Consort Medical plc, Douglas Pharmaceuticals Ltd., ENT Technologies Pty. Ltd., Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Boehringer Ingelheim International GmbH, Bayer AG, Abbott Laboratories, Eli Lilly and Company, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Amgen Inc., Gilead Sciences Inc., Biogen Inc., Roche Holding AG, Allergan plc, Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals Inc.

North America was the largest region in the nasal drug delivery technology market in 2024. The regions covered in the nasal drug delivery technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the nasal drug delivery technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The nasal drug delivery technology market consists of revenues earned by entities by providing services such as intranasal drug delivery services, brain-targeted therapy, and mucosal vaccination. The market value includes the value of related goods sold by the service provider or included within the service offering. The nasal drug delivery technology market also includes sales of catheter-delivered drugs, nebulizers, and pressurized metered-dose inhalers (PMDIs) equipment which are used in providing nasal drug delivery technology services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nasal Drug Delivery Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nasal drug delivery technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nasal drug delivery technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nasal drug delivery technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Dosage Form: Nasal Spray; Nasal Drops; Nasal Gels And Ointments; Nasal Powders; Other Dosage Forms
  • 2) By Container Type: Pressurized Containers; Non-Pressurized Containers
  • 3) By Therapeutic Application: Allergic And Non-Allergic Rhinitis; Nasal Congestion; Asthma; Vaccination; Other Therapeutic Applications
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • 5) By End User: Home Care Settings; Hospitals
  • Subsegments:
  • 1) By Nasal Spray: Metered-Dose Spray; Non-Metered-Dose Spray
  • 2) By Nasal Drops: Liquid Nasal Drops; Gel-Based Nasal Drops
  • 3) By Nasal Gels and Ointments: Hydrogel Formulations; Oil-Based Ointments
  • 4) By Nasal Powders: Dry Powder Inhalers (DPI); Spray-Dried Powders
  • 5) By Other Dosage Forms: Nasal Patches; Nasal Inserts
  • Companies Mentioned: AptarGroup Inc.; Becton Dickinson and Company; GlaxoSmithKline plc; Johnson & Johnson Private Limited; Novartis AG; Pfizer Inc.; 3M Company; Cadila Healthcare Limited; Neurelis Inc.; OptiNose Inc.; Bausch Health Companies Inc.; Naveh Pharma Ltd.; Teva Pharmaceutical Industries Ltd.; Consort Medical plc; Douglas Pharmaceuticals Ltd.; ENT Technologies Pty. Ltd.; Merck & Co. Inc.; Sanofi SA; AstraZeneca plc; Boehringer Ingelheim International GmbH; Bayer AG; Abbott Laboratories; Eli Lilly and Company; Bristol-Myers Squibb Company; Takeda Pharmaceutical Company Limited; Amgen Inc.; Gilead Sciences Inc.; Biogen Inc.; Roche Holding AG; Allergan plc; Regeneron Pharmaceuticals Inc.; Alexion Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nasal Drug Delivery Technology Market Characteristics

3. Nasal Drug Delivery Technology Market Trends And Strategies

4. Nasal Drug Delivery Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Nasal Drug Delivery Technology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Nasal Drug Delivery Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Nasal Drug Delivery Technology Market Growth Rate Analysis
  • 5.4. Global Nasal Drug Delivery Technology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Nasal Drug Delivery Technology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Nasal Drug Delivery Technology Total Addressable Market (TAM)

6. Nasal Drug Delivery Technology Market Segmentation

  • 6.1. Global Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nasal Spray
  • Nasal Drops
  • Nasal Gels And Ointments
  • Nasal Powders
  • Other Dosage Forms
  • 6.2. Global Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pressurized Containers
  • Non-Pressurized Containers
  • 6.3. Global Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Allergic And Non-Allergic Rhinitis
  • Nasal Congestion
  • Asthma
  • Vaccination
  • Other Therapeutic Applications
  • 6.4. Global Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.5. Global Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Home Care Settings
  • Hospitals
  • 6.6. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Nasal Spray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metered-Dose Spray
  • Non-Metered-Dose Spray
  • 6.7. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Nasal Drops, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Nasal Drops
  • Gel-Based Nasal Drops
  • 6.8. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Nasal Gels and Ointments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hydrogel Formulations
  • Oil-Based Ointments
  • 6.9. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Nasal Powders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dry Powder Inhalers (DPI)
  • Spray-Dried Powders
  • 6.10. Global Nasal Drug Delivery Technology Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nasal Patches
  • Nasal Inserts

7. Nasal Drug Delivery Technology Market Regional And Country Analysis

  • 7.1. Global Nasal Drug Delivery Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Nasal Drug Delivery Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nasal Drug Delivery Technology Market

  • 8.1. Asia-Pacific Nasal Drug Delivery Technology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nasal Drug Delivery Technology Market

  • 9.1. China Nasal Drug Delivery Technology Market Overview
  • 9.2. China Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nasal Drug Delivery Technology Market

  • 10.1. India Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nasal Drug Delivery Technology Market

  • 11.1. Japan Nasal Drug Delivery Technology Market Overview
  • 11.2. Japan Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nasal Drug Delivery Technology Market

  • 12.1. Australia Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nasal Drug Delivery Technology Market

  • 13.1. Indonesia Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nasal Drug Delivery Technology Market

  • 14.1. South Korea Nasal Drug Delivery Technology Market Overview
  • 14.2. South Korea Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nasal Drug Delivery Technology Market

  • 15.1. Western Europe Nasal Drug Delivery Technology Market Overview
  • 15.2. Western Europe Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nasal Drug Delivery Technology Market

  • 16.1. UK Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nasal Drug Delivery Technology Market

  • 17.1. Germany Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nasal Drug Delivery Technology Market

  • 18.1. France Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nasal Drug Delivery Technology Market

  • 19.1. Italy Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nasal Drug Delivery Technology Market

  • 20.1. Spain Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nasal Drug Delivery Technology Market

  • 21.1. Eastern Europe Nasal Drug Delivery Technology Market Overview
  • 21.2. Eastern Europe Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nasal Drug Delivery Technology Market

  • 22.1. Russia Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nasal Drug Delivery Technology Market

  • 23.1. North America Nasal Drug Delivery Technology Market Overview
  • 23.2. North America Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nasal Drug Delivery Technology Market

  • 24.1. USA Nasal Drug Delivery Technology Market Overview
  • 24.2. USA Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nasal Drug Delivery Technology Market

  • 25.1. Canada Nasal Drug Delivery Technology Market Overview
  • 25.2. Canada Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nasal Drug Delivery Technology Market

  • 26.1. South America Nasal Drug Delivery Technology Market Overview
  • 26.2. South America Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nasal Drug Delivery Technology Market

  • 27.1. Brazil Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nasal Drug Delivery Technology Market

  • 28.1. Middle East Nasal Drug Delivery Technology Market Overview
  • 28.2. Middle East Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nasal Drug Delivery Technology Market

  • 29.1. Africa Nasal Drug Delivery Technology Market Overview
  • 29.2. Africa Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nasal Drug Delivery Technology Market Competitive Landscape And Company Profiles

  • 30.1. Nasal Drug Delivery Technology Market Competitive Landscape
  • 30.2. Nasal Drug Delivery Technology Market Company Profiles
    • 30.2.1. AptarGroup Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Nasal Drug Delivery Technology Market Other Major And Innovative Companies

  • 31.1. Pfizer Inc.
  • 31.2. 3M Company
  • 31.3. Cadila Healthcare Limited
  • 31.4. Neurelis Inc.
  • 31.5. OptiNose Inc.
  • 31.6. Bausch Health Companies Inc.
  • 31.7. Naveh Pharma Ltd.
  • 31.8. Teva Pharmaceutical Industries Ltd.
  • 31.9. Consort Medical plc
  • 31.10. Douglas Pharmaceuticals Ltd.
  • 31.11. ENT Technologies Pty. Ltd.
  • 31.12. Merck & Co. Inc.
  • 31.13. Sanofi SA
  • 31.14. AstraZeneca plc
  • 31.15. Boehringer Ingelheim International GmbH

32. Global Nasal Drug Delivery Technology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nasal Drug Delivery Technology Market

34. Recent Developments In The Nasal Drug Delivery Technology Market

35. Nasal Drug Delivery Technology Market High Potential Countries, Segments and Strategies

  • 35.1 Nasal Drug Delivery Technology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Nasal Drug Delivery Technology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Nasal Drug Delivery Technology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer